These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 7497577

  • 1. Pharmacokinetics and antitumor activity of a new platinum compound, cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1, 3- dioxolane]platinum(II), as determined by ex vivo pharmacodynamics.
    Kim DK, Kim HT, Tai JH, Cho YB, Kim TS, Kim KH, Park JG, Hong WS.
    Cancer Chemother Pharmacol; 1995; 37(1-2):1-6. PubMed ID: 7497577
    [Abstract] [Full Text] [Related]

  • 2. In vitro cytotoxicity, pharmacokinetics and ex vivo pharmacodynamics of a new platinum compound, cis-malonato [(4R,5R-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclopentane] platinum (II).
    Kim DK, Kim HT, Cho YB, Kim TS, Kim KH, Hong WS.
    Anticancer Res; 1996; 16(1):251-6. PubMed ID: 8615617
    [Abstract] [Full Text] [Related]

  • 3. Antitumor activity of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2- isopropyl-1,3-dioxolane]platinum(II), a new platinum analogue, as an anticancer agent.
    Kim DK, Kim HT, Cho YB, Tai JH, Ahn JS, Kim TS, Kim KH, Hong WS.
    Cancer Chemother Pharmacol; 1995; 35(5):441-5. PubMed ID: 7850928
    [Abstract] [Full Text] [Related]

  • 4. In vitro antitumor activity of a new platinum complex, cis-malonato [(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane] platinum (II) (SKI 2053R), against human lung and stomach cancer cell lines.
    Hong WS, Kim HT, Kim KH, Kim DK.
    Anticancer Res; 1995; 15(1):51-4. PubMed ID: 7733640
    [Abstract] [Full Text] [Related]

  • 5. Influence of exposure and infusion times on the cytotoxicity and pharmacokinetics of cis-malonato[(4R, 5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane]platinum(II) .
    Kim HT, Kim DK, Cho YB, Kim TS, Jung I, Kim KH, Heo DS, Bang YJ, Shin SG, Kim NK.
    Cancer Chemother Pharmacol; 1998; 41(2):109-16. PubMed ID: 9443623
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics, tissue distribution, and excretion of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II) in dogs.
    Cho YB, Kim KH, Kim DK.
    Drug Metab Dispos; 1995 Nov; 23(11):1280-5. PubMed ID: 8591731
    [Abstract] [Full Text] [Related]

  • 7. General pharmacology of cis-malonato[4R,5R)-4,5-bis-(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II).
    Kim DK, Ahn JS, Ryu G, Kim KH, Park CW, Kim MS, Chung MH, Shin SG, Suh YH, Kim YS.
    Arzneimittelforschung; 1994 Sep; 44(9):1080-8. PubMed ID: 7986249
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of platinum following the administration of cis-(glycolato-O,O')[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1, 3-dioxolane]platinum(II) in dogs.
    Kim DK, Kim HT, Cho YB, Kim TS, Kim KH, Hong WS.
    Anticancer Res; 1997 Sep; 17(5A):3681-3. PubMed ID: 9413223
    [Abstract] [Full Text] [Related]

  • 9. A Phase I study of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane] platinum(II) in patients with advanced malignancies.
    Kim NK, Kim TY, Shin SG, Park YI, Lee JA, Cho YB, Kim KH, Kim DK, Heo DS, Bang YJ.
    Cancer; 2001 Apr 15; 91(8):1549-56. PubMed ID: 11301404
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of a new platinum compound, cis-(glycolato-O,O) [(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclohexane]plat inum (II) in dogs.
    Kim DK, Cho YB, Kim HT, Kim TS, Kim KH, Hong WS.
    Anticancer Res; 1996 Apr 15; 16(3A):1167-9. PubMed ID: 8702230
    [Abstract] [Full Text] [Related]

  • 11. Mammary excretion and placental transfer of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane] platinum(II) in rats.
    Cho YB, Kim KH, Kim DK, Miyamoto G.
    Arzneimittelforschung; 1996 Sep 15; 46(9):926-30. PubMed ID: 8876944
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Embryotoxic effects of SKI 2053R, a new potential anticancer agent, in rats.
    Chung MK, Kim JC, Roh JK.
    Reprod Toxicol; 1998 Sep 15; 12(3):375-81. PubMed ID: 9628560
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model.
    Chang MJ, Yu WD, Reyno LM, Modzelewski RA, Egorin MJ, Erkmen K, Vlock DR, Furmanski P, Johnson CS.
    Cancer Res; 1994 Oct 15; 54(20):5380-6. PubMed ID: 7923169
    [Abstract] [Full Text] [Related]

  • 20. In vitro antitumor activity of a new platinum complex, DWA2114R against human tumor cell lines.
    Akamatsu K, Saito H, Tsunenari T, Matsumoto T, Morikawa K, Koizumi M, Mitsui H, Koizumi K.
    Anticancer Res; 1993 Oct 15; 13(6A):2261-5. PubMed ID: 8297143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.